Our data demonstrate, for the first time, that the LCn3-PUFA, EPA and DHA, decrease both ACE1 and ACE2 protein levels in human EA.hy926 endothelial and HEK293 cells, and in key COVID-19-sensitive tissues of obese rats. The gene discussed is ACE; the disease is COVID-19.